Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, replacing the previous version tag as part of a minor maintenance update to the page’s documentation/versioning.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.6.4 replaces the previous v3.6.3 on the page. This indicates a minor update to the page's metadata or formatting rather than any change to the study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the page. This update does not modify any study details or how the page is used.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision label has been updated from v3.6.0 to v3.6.2. This reflects a recent update to the page's revision metadata and does not modify the visible study content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users, and it updates the recruitment status to show that no participants are being sought, along with a minor formatting/name change to the Intervention/Treatment label and a revision note.SummaryDifference0.4%

- Check66 days agoChange DetectedRevision label updated to v3.5.5, indicating a new iteration of the page. There is no apparent user-facing content change accompanying this update.SummaryDifference0.1%

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.